Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability. Lorna Rothery spoke to the team about the effects of pharmaceutical pollution and the necessity for the industry to adopt greener practices.
NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.
Here, we look at medical devices policy of Japan’s Ministry of Health, Labour and Welfare. The Ministry now has Katsunobu Katō in place, who very recently replaced Nemoto Takumi as the Minister of Health, Labour and Welfare in the country.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the importance of getting your chemistry right.
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, explains how they are recognised internationally as a hub of process innovation and advanced manufacturing for the pharmaceutical sector.
AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
Lupus is on the rise, yet awareness of the disease remains relatively low. However, efforts are underway to tackle existing gaps in managing the condition, as we discover here.
Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
MediConnect is pleased to announce that it has received indicative support from the Ugandan government to explore the use of its solution to tackle the spread of counterfeit drugs.
The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
